Ronald joined Foley directly from the Department of Justice, where he was a member of the firm’s Intellectual Property Litigation and Antitrust Practices. During his tenure at the firm, he was involved in complex litigation matters in numerous venues throughout the United States. The subjects of this litigation included antitrust, patent, and general commercial disputes.

While at the Department of Justice, Ronald worked on a number of significant patent cases, including the Tetracycline and Ampicillin litigations. He also handled grand jury investigations relating to fraud on the Patent Office and the antitrust implications of enforcing patents known to be invalid. In addition to patent litigation, Ronald served as lead counsel in numerous jury trials. His trial experience encompassed matters involving RICO, securities fraud, product liability, patents, legal malpractice, and other complex issues.

Several of Ronald’s cases were particularly noteworthy. One involved a client’s claim against a bank that allegedly defrauded her to protect the bank’s loan position with a closely held company. Following a three‑week jury trial, the jury returned a verdict finding the bank liable for fraud and guilty of outrageous conduct. Another case involved a patent infringement claim against a large national retail chain and other defendants, resulting in a jury verdict of willful infringement and the entry of an immediate injunction. A subsequent motion for contempt for violating the injunction was granted, and the case settled shortly thereafter with a judgment well in excess of seven figures. Notably, Ronald tried the matter to conclusion and secured the settlement in less than one year.

Ronald also served as lead trial counsel in litigation relating to one of Michael Milken’s final junk bond deals. Bonds bearing interest rates as high as 21 percent were sold to purchasers, including Ronald’s clients. Although the prospectus disclosed certain operational challenges, the bondholders were unaware that the issuer was insolvent. Following discovery, the case settled for a seven‑figure payment to Ronald’s clients.

In addition, Ronald was active in defending clients against antitrust challenges related to their distribution systems. He represented Fortune 500 companies nationwide in these matters and successfully obtained no‑liability defense judgments in numerous cases.

In recognition of his achievements, Ronald was Peer Review Rated AV® Preeminent™, the highest performance rating in Martindale‑Hubbell’s peer review rating system.

Ronald received his bachelor’s degree from the University of Wisconsin–Madison, where he majored in pharmacy and studied inorganic, organic, and biochemistry. After graduating from the School of Pharmacy, he worked as a registered pharmacist in hospital and retail settings and taught at the University of Wisconsin School of Pharmacy. His J.D. degree was conferred by the University of Wisconsin in 1972.